📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Anti-EGFR Antibody-Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth. (2024)

First Author: Cheung A

Attributed to: Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-23-3110

PubMed Identifier: 38772416

Publication URI: http://europepmc.org/abstract/MED/38772416

Type: Journal Article/Review

Volume: 30

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 15

ISSN: 1078-0432